Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MARK1

RBC: MARK1 · Substrate: CHKtide ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Midostaurin93.40.50
Brigatinib82.50.51
Defactinib64.20.45
Axitinib58.60.69
Baricitinib54.40.62
Repotrectinib48.80.61
Sunitinib44.60.52
Pemigatinib40.70.72
Crizotinib30.70.58
Upadacitinib29.60.66
Ruxolitinib26.70.59
Neratinib19.90.60
Pacritinib15.90.45
Bosutinib15.50.55
Canertinib13.30.67

Known variants

No variants catalogued.
Open in new tab